Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Question

<< Previous

Bullboard Posts

Next >>

Comment by Gorf79on Jul 16, 2022 11:10am

214 Views

Post# 34828982

RE:Question

My EBIDITA And NPV analysis for a takeout of the whole pie is roughly $27.00 for the PMX division and $25.00 for Dialco.

I believe Spectral are ultra conservatively projecting about half of the actual potential revenues for both divisions at their latest AGM.

Call it a minimum of $52.00 per share all up all in.

That took me about 24 hours of analysis and research to derive, but I believe it is an accurate representation of Asset Values.

The current share price is completely un tethered from the reality of Spectral's asset values.

Yep $52.00 is a fair takeout price in my books!

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China